Indigo Diabetes increased its total funding to $52.6m with a series B round backed by Ackermans & van Haaren.

Enthera Pharmaceuticals was co-founded by faculty from University of Milan and is using stem cells to treat autoimmune disorders.

CureVac has filed for an initial public offering in the US, 20 years after being spun out of Eberhard Karls University of Tübingen.

Thought Machine has added $42m to its series B round, bringing its total to $125m and welcoming SEB as a new investor.

GlaxoSmithKline is in line for an exit as CureVac files for an initial public offering in the US, 20 years after being spun out of Eberhard Karls University of Tübingen.

Indigo Diabetes increased its total funding to $52.6m with a series B round backed by Imec.xpand and returning investor Qbic.

Existing backer Hughes Network Systems has committed $50m to join Bharti Enterprises and the UK government in acquiring the bankrupt satellite internet services provider.

Deutsche Telekom has invested in Everphone’s series B round as the company expects a shift to remote work will bolster demand for its device leasing service.

AbbVie Ventures and Sofinnova Partners have co-led a series A round for Enthera Pharmaceuticals, which is using stem cells to treat autoimmune disorders.

Credit Agricole returned to reinvest in the solar and biomethane project developer having contributed to a $122m debt round in May.